Jorgensen Nathan D. — SEC Form 4 filings
SEC reporting owner CIK 1842523. 11 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-31 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 12,334 shares, $54,242 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 7,666 shares @ $4.78 ($36,643) in Voyager Therapeutics, Inc., filed 2025-10-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | Chief Financial Officer | 6 | — | 2 legs · 12,334 sh · $54,242 | 6 |
| Vor Biopharma Inc. (VOR) | CHIEF FINANCIAL OFFICER | 5 | — | — | 6 |
Form 4 filings — Jorgensen Nathan D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 4,668 @ $3.77 | EDGAR |
| 2026-02-10 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 32,250 @ $0 · Grant/award (A): 150,500 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 7,666 @ $4.78 | EDGAR |
| 2025-02-24 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 51,500 @ $0 · Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 80,000 @ $0 | EDGAR |
| 2024-07-09 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Vor Biopharma Inc. (VOR) | Tax withholding (F): 834 @ $1.75 | EDGAR |
| 2024-05-03 | 4 | Vor Biopharma Inc. (VOR) | Tax withholding (F): 917 @ $1.77 | EDGAR |
| 2024-03-05 | 4 | Vor Biopharma Inc. (VOR) | Tax withholding (F): 6,310 @ $2.27 | EDGAR |
| 2024-02-08 | 4 | Vor Biopharma Inc. (VOR) | Tax withholding (F): 985 @ $2.32 | EDGAR |
| 2024-01-31 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1842523 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →